2. Search Result
Search Result
Results for "

SK1

" in MedChemExpress (MCE) Product Catalog:

16

Inhibitors & Agonists

2

Recombinant Proteins

2

Antibodies

3

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-15425
    PF-543
    Maximum Cited Publications
    22 Publications Verification

    Sphingosine Kinase 1 Inhibitor II

    		 SphK LPL Receptor Apoptosis Autophagy Cardiovascular Disease Inflammation/Immunology Cancer
    PF-543 (Sphingosine Kinase 1 Inhibitor II) is a potent, selective, reversible and sphingosine-competitive SPHK1 inhibitor with an IC50 of 2 nM and a Ki of 3.6 nM. PF-543 is >100-fold selectivity for SPHK1 over SPHK2. PF-543 is an effective potent inhibitor of sphingosine 1-phosphate (S1P) formation in whole blood with an IC50 of 26.7 nM. PF-543 induces apoptosis, necrosis, and autophagy [1] .
    PF-543
  • HY-13822
    SKI II
    5+ Cited Publications

    		 SphK Wnt Apoptosis Cancer
    SKI-II is an oral active and synthetic inhibitor of sphingosine kinase (SK) activity, with IC50 values of 78 μM and 45 μM for SK1 and for SK2, respectively. SKI II causes an irreversible inhibition of SK1 by inducing its lysosomal and/or proteasomal degradation [1] .
    SKI II
  • HY-110105
    NS8593 hydrochloride
    1 Publications Verification

    		 Potassium Channel Neurological Disease
    NS8593 hydrochloride is a potent and selective small conductance Ca 2+-activated K + channels (SK channels) inhibitor. NS8593 hydrochloride reversibly inhibits SK3-mediated currents with a Kd value of 77 nM. NS8593 hydrochloride inhibits all the SK1-3 subtypes Ca 2+-dependently (Kds of 0.42, 0.60, and 0.73 μM, respectively, at 0.5 μM Ca 2+), and does not affect the Ca 2+-activated K + channels of intermediate and large conductance (hIK and hBK channels, respectively) [1] .
    NS8593 hydrochloride
  • HY-15425A
    PF-543 Citrate
    Maximum Cited Publications
    22 Publications Verification

    Sphingosine Kinase 1 Inhibitor II Citrate

    		 SphK LPL Receptor Apoptosis Autophagy Cardiovascular Disease Inflammation/Immunology Cancer
    PF-543 Citrate (Sphingosine Kinase 1 Inhibitor II Citrate) is a potent, selective, reversible and sphingosine-competitive SPHK1 inhibitor with an IC50 of 2 nM and a Ki of 3.6 nM. PF-543 Citrate is >100-fold selectivity for SPHK1 over SPHK2. PF-543 Citrate is an effective potent inhibitor of sphingosine 1-phosphate (S1P) formation in whole blood with an IC50 of 26.7 nM. PF-543 Citrate induces apoptosis, necrosis, and autophagy [1] .
    PF-543 Citrate
  • HY-119016
    SK1-I
    1 Publications Verification

    BML-258

    		 SphK CaMK Cancer
    SK1-I (BML-258), an analog of sphingosine, is an isozyme-specific competitive SPHK1 inhibitor with a Ki value of 10 μM [1]. SK1-I shows no activity at SPHK1 PKCα, PKCδ, PKA, AKT1, ERK1, EGFR, CDK2, IKKβ or CamK2β. SK1-I enhances autophagy and has antitumor activity .
    SK1-I
  • HY-101805
    SK1-IN-1
    2 Publications Verification

    		 SphK Inflammation/Immunology Cancer
    SK1-IN-1 is a potent sphingosine kinase 1 (SPHK1) inhibitor with an IC50 of 58 nM.
    SK1-IN-1
  • HY-137952
    NS8593

    		Potassium Channel TRP Channel Neurological Disease
    NS8593 is an SK channel (small conductance Ca 2+-activated K+ channels) inhibitor. NS8593 reversibly inhibited recombinant SK3-mediated currents (human SK3 and rat SK3). NS8593 inhibits all the SK1-3 subtypes Ca 2+-dependently (Kd = 0.42, 0.60, and 0.73 μM, respectively, at 0.5 μM Ca 2+). NS8593 does not affect the Ca 2+-activated K channels of intermediate and large conductance (hlk and hBK channels, respectively). NS8593 can also inhibit TRPM7 (melastatin-related TRP cation channel 7) (IC50 = 1.6 mM). NS8593 can be used for the study of central nervous system (CNS) related diseases [1] .
    NS8593
  • HY-15425B
    PF-543 hydrochloride

    Sphingosine Kinase 1 Inhibitor II hydrochloride

    		 SphK LPL Receptor Apoptosis Autophagy Cardiovascular Disease Inflammation/Immunology Cancer
    PF-543 hydrochloride (Sphingosine Kinase 1 Inhibitor II hydrochloride) is a potent, selective, reversible and sphingosine-competitive SPHK1 inhibitor with an IC50 of 2 nM and a Ki of 3.6 nM. PF-543 hydrochloride is >100-fold selectivity for SPHK1 over SPHK2. PF-543 hydrochloride is an effective potent inhibitor of sphingosine 1-phosphate (S1P) formation in whole blood with an IC50 of 26.7 nM. PF-543 hydrochloride induces apoptosis, necrosis, and autophagy [1] .
    PF-543 hydrochloride
  • HY-112485
    (R)-FTY720-vinylphosphonate

    		SphK Drug Derivative Cancer
    (R)-FTY720-vinylphosphonate is a sphingosine kinase 1 (SK1) inhibitor. (R)-FTY720-ene-phosphonate is also an FTY720 analogue. (R)-FTY720-vinylphosphonate is promising for research of solid tumors like breast cancer [1].
    (R)-FTY720-vinylphosphonate
  • HY-12900
    RB-005

    		SphK Inflammation/Immunology Cancer
    RB-005 is a selective inhibitor of sphingosine kinase 1 (SK1) (IC50=3.6 µM), with weaker inhibition of another isoenzyme, SK2. The selective inhibition of RB-005 helps to distinguish the biological functions and roles of SK1 and SK2, which can be used in the study of inflammatory diseases and cancer [1].
    RB-005
  • HY-101805R
    SK1-IN-1 (Standard)

    		Reference Standards SphK Inflammation/Immunology Cancer
    SK1-IN-1 (Standard) is the analytical standard of SK1-IN-1 (HY-101805). This product is intended for research and analytical applications. SK1-IN-1 is a potent sphingosine kinase 1 (SPHK1) inhibitor with an IC50 of 58 nM.
    SK1-IN-1 (Standard)
  • HY-124368
    RB-042

    		SphK Inflammation/Immunology
    RB-042 is a SK1 and SK2 inhibitor with IC50 values of 5.3 μM and 5.0 μM, respectively. RB-042 is applicable to the research of inflammatory diseases [1] .
    RB-042
  • HY-112385
    ABC294735

    		SphK PERK Cancer
    ABC294735 is an orally active SK1/SK2 inhibitor. Combination of ABC294735 with Sorafenib (HY-10201) reduces pERK. ABC294735 exhibits anticancer activity against pancreatic adenocarcinoma and renal cell carcinoma. ABC294735 can be used in research related to pancreatic adenocarcinoma and renal cell carcinoma [1].
    ABC294735
  • HY-RS10030
    PAPSS1 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    PAPSS1 Human Pre-designed siRNA Set A contains three designed siRNAs for PAPSS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    PAPSS1 Human Pre-designed siRNA Set A
    PAPSS1 Human Pre-designed siRNA Set A
  • HY-RS13665
    Sphk1 Mouse Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) SphK Others

    Sphk1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sphk1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Sphk1 Mouse Pre-designed siRNA Set A
    Sphk1 Mouse Pre-designed siRNA Set A
  • HY-RS07169
    KCNN1 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    KCNN1 Human Pre-designed siRNA Set A contains three designed siRNAs for KCNN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    KCNN1 Human Pre-designed siRNA Set A
    KCNN1 Human Pre-designed siRNA Set A

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: